Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 2
1995 1
1996 6
1997 6
1998 2
1999 3
2000 4
2001 4
2002 3
2003 2
2004 2
2005 5
2006 3
2008 3
2009 1
2010 3
2012 2
2013 4
2014 2
2015 2
2017 2
2018 2
2019 2
2020 2
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

63 results
Results by year
Filters applied: . Clear all
Page 1
Phase II trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-amplified well-differentiated or dedifferentiated liposarcoma.
Dickson MA, Tap WD, Keohan ML, D'Angelo SP, Gounder MM, Antonescu CR, Landa J, Qin LX, Rathbone DD, Condy MM, Ustoyev Y, Crago AM, Singer S, Schwartz GK. Dickson MA, et al. Among authors: rathbone dd. J Clin Oncol. 2013 Jun 1;31(16):2024-8. doi: 10.1200/JCO.2012.46.5476. Epub 2013 Apr 8. J Clin Oncol. 2013. PMID: 23569312 Free PMC article. Clinical Trial.
Biotransformation of alkaloids.
Rathbone DA, Lister DL, Bruce NC. Rathbone DA, et al. Alkaloids Chem Biol. 2002;58:1-82. doi: 10.1016/s0099-9598(02)58002-0. Alkaloids Chem Biol. 2002. PMID: 12534248 Review.
Biotransformation of alkaloids.
Rathbone DA, Lister DL, Bruce NC. Rathbone DA, et al. Alkaloids Chem Biol. 2001;57:1-74. doi: 10.1016/s0099-9598(01)57002-9. Alkaloids Chem Biol. 2001. PMID: 11705120 Review.
Microbial transformation of alkaloids.
Rathbone DA, Bruce NC. Rathbone DA, et al. Curr Opin Microbiol. 2002 Jun;5(3):274-81. doi: 10.1016/s1369-5274(02)00317-x. Curr Opin Microbiol. 2002. PMID: 12057681 Review.
63 results